IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.235
+0.045 (3.78%)
Apr 17, 2025, 4:00 PM EDT - Market closed
IGM Biosciences Employees
IGM Biosciences had 149 employees as of December 31, 2024. The number of employees decreased by 75 or -33.48% compared to the previous year.
Employees
149
Change (1Y)
-75
Growth (1Y)
-33.48%
Revenue / Employee
$17,980
Profits / Employee
-$1,314,060
Market Cap
72.93M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
IGMS News
- 3 months ago - IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out - Market Watch
- 3 months ago - IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs - GlobeNewsWire
- 5 months ago - IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - IGM Biosciences to Present at Three Upcoming Investor Conferences - GlobeNewsWire
- 7 months ago - IGM Biosciences' stock tumbles as analysts weigh in on pivot plan with dismay - Market Watch
- 7 months ago - IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO - Benzinga
- 7 months ago - IGM Biosciences Stock Drops 27% on ‘Pipeline Transformation' to Autoimmune Diseases - Barrons
- 7 months ago - IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga